A novel cysteine-free venom peptide with strong antimicrobial activity against antibiotics-resistant pathogens from the scorpion Opistophthalmus glabrifrons

Antibiotic‐resistant bacteria, such as methicillin‐resistant Staphylococcus aureus and vancomycin‐resistant Enterococcus, pose serious threat to human health. The outbreak of antibiotic‐resistant pathogens in recent years emphasizes once again the urgent need for the development of new antimicrobial...

Full description

Saved in:
Bibliographic Details
Published inJournal of peptide science Vol. 21; no. 10; pp. 758 - 764
Main Authors Bao, Aorigele, Zhong, Jie, Zeng, Xian-Chun, Nie, Yao, Zhang, Lei, Peng, Zhao Feng
Format Journal Article
LanguageEnglish
Published England Blackwell Publishing Ltd 01.10.2015
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Antibiotic‐resistant bacteria, such as methicillin‐resistant Staphylococcus aureus and vancomycin‐resistant Enterococcus, pose serious threat to human health. The outbreak of antibiotic‐resistant pathogens in recent years emphasizes once again the urgent need for the development of new antimicrobial agents. Here, we discovered a novel antimicrobial peptide from the scorpion Opistophthalmus glabrifrons, which was referred to as Opisin. Opisin consists of 19 amino acid residues without disulfide bridges. It is a cationic, amphipathic, and α‐helical molecule. Protein sequence homology search revealed that Opisin shares 42.1–5.3% sequence identities to the 17/18‐mer antimicrobial peptides from scorpions. Antimicrobial assay showed that Opisin is able to potently inhibit the growth of the tested Gram‐positive bacteria with the minimal inhibitory concentration (MIC) values of 4.0–10.0 μM; in contrast, it possesses much lower activity against the tested Gram‐negative bacteria and a fungus. It is interesting to see that Opisin is able to strongly inhibit the growth of methicillin‐ and vancomycin‐resistant pathogens with the MICs ranging from 2.0 to 4.0 μM and from 4.0 to 6.0 μM, respectively. We found that at a concentration of 5 × MIC, Opisin completely killed all the cultured methicillin‐resistant Staphylococcus aureus. These results suggest that Opisin is a promising therapeutic candidate for the treatment of the antibiotic‐resistant bacterial infections. Copyright © 2015 European Peptide Society and John Wiley & Sons, Ltd. A novel antimicrobial peptide, referred to as Opisin, was discovered from the scorpion Opistophthalmus glabrifrons. Opisin possesses strong antimicrobial activity against antibiotics‐resistant pathogens, such as methicillin‐resistant Staphylococcus aureus (MRSA) and vancomycin‐resistant Enterococcus (VRE). This suggests that Opisin has great potential for the treatment of infections caused by MRSA and VRE.
Bibliography:The cDNA of Opisin has been deposited in the GenBank database under the accession number of KJ995735.
China National 973 Research Project, Basic Research and Clinical Application of Venom Peptides from Toxic Animals - No. 2010CB529800
Fundamental Research Fund for the Central Universities - No. CUGL100613; No. CUGL110604; No. CUGL120608
istex:88259DB3E207410BBA93D0763067A7E29E1C2C2C
ark:/67375/WNG-CGM452DP-C
ArticleID:PSC2801
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1075-2617
1099-1387
DOI:10.1002/psc.2801